...
首页> 外文期刊>American journal of psychiatry >Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
【24h】

Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.

机译:在双极性躁狂症患者中对丙戊酸/锂单一疗法无反应的辅助阿立哌唑对丙戊酸或锂的疗效:一项安慰剂对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The authors evaluated the efficacy and safety of adjunctive aripiprazole in bipolar I patients with mania partially nonresponsive to lithium/valproate monotherapy. METHOD: This multicenter, randomized, placebo-controlled study included outpatients experiencing a manic or mixed episode (with or without psychotic features). Patients with partial nonresponse to lithium/valproate monotherapy (defined as a Young Mania Rating Scale total score >/=16 at the end of phases 1 and 2, with a decrease of
机译:目的:作者评价了阿立哌唑辅助治疗I型躁狂型躁郁症患者对锂/丙戊酸单药治疗无反应的疗效和安全性。方法:这项多中心,随机,安慰剂对照研究包括经历躁狂或混合发作(有或没有精神病特征)的门诊患者。锂/丙戊酸单药治疗部分无反应的患者(定义为1期和2期末的年轻躁狂评分量表总得分> / = 16,两期之间降低

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号